US Bancorp’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.4K Sell
1,976
-216
-10% -$2.24K ﹤0.01% 3191
2025
Q4
$27.1K Sell
2,192
-155
-7% -$1.66K ﹤0.01% 2955
2025
Q3
$20.7K Sell
2,347
-1,447
-38% -$11.3K ﹤0.01% 3054
2025
Q2
$24.2K Buy
3,794
+3,074
+427% +$17.6K ﹤0.01% 3102
2025
Q1
$3.5K Buy
720
+455
+172% +$3.77K ﹤0.01% 3753
2024
Q4
$2.53K Hold
265
﹤0.01% 3812
2024
Q3
$2.21K Hold
265
﹤0.01% 3767
2024
Q2
$1.81K Hold
265
﹤0.01% 3735
2024
Q1
$670 Sell
265
-351
-57% -$791 ﹤0.01% 3843
2023
Q4
$1.48K Sell
616
-62
-9% -$146 ﹤0.01% 3749
2023
Q3
$2.31K Sell
678
-174
-20% -$965 ﹤0.01% 3630
2023
Q2
$6.26K Sell
852
-1,306
-61% -$12.1K ﹤0.01% 3417
2023
Q1
$22.4K Sell
2,158
-1,720
-44% -$20.8K ﹤0.01% 2935
2022
Q4
$45.8K Sell
3,878
-925
-19% -$14.3K ﹤0.01% 2578
2022
Q3
$101K Buy
4,803
+1,213
+34% +$33.8K ﹤0.01% 2188
2022
Q2
$112K Sell
3,590
-1,061
-23% -$36.2K ﹤0.01% 2177
2022
Q1
$191K Sell
4,651
-1,575
-25% -$69.5K ﹤0.01% 1967
2021
Q4
$271K Buy
6,226
+1,495
+32% +$67.6K ﹤0.01% 1831
2021
Q3
$237K Buy
4,731
+81
+2% +$4.91K ﹤0.01% 1885
2021
Q2
$293K Sell
4,650
-3,608
-44% -$232K ﹤0.01% 1815
2021
Q1
$767K Sell
8,258
-4,633
-36% -$475K ﹤0.01% 1278
2020
Q4
$1.16M Buy
12,891
+3,997
+45% +$367K ﹤0.01% 1039
2020
Q3
$919K Buy
8,894
+3,588
+68% +$387K ﹤0.01% 1041
2020
Q2
$419K Sell
5,306
-1,096
-17% -$81.7K ﹤0.01% 1392
2020
Q1
$370K Sell
6,402
-1,118
-15% -$64.4K ﹤0.01% 1371
2019
Q4
$405K Sell
7,520
-304
-4% -$16.5K ﹤0.01% 1475
2019
Q3
$409K Sell
7,824
-2,031
-21% -$94.6K ﹤0.01% 1468
2019
Q2
$476K Sell
9,855
-13,319
-57% -$638K ﹤0.01% 1427
2019
Q1
$1.17M Buy
23,174
+1,221
+6% +$72K ﹤0.01% 994
2018
Q4
$1.3M Sell
21,953
-2,104
-9% -$136K ﹤0.01% 892
2018
Q3
$1.58M Sell
24,057
-1,268
-5% -$74K ﹤0.01% 904
2018
Q2
$1.28M Sell
25,325
-1,760
-6% -$91.7K ﹤0.01% 988
2018
Q1
$1.43M Sell
27,085
-1,493
-5% -$74.4K ﹤0.01% 930
2017
Q4
$1.33M Sell
28,578
-8,920
-24% -$375K ﹤0.01% 968
2017
Q3
$1.52M Sell
37,498
-3,192
-8% -$115K ﹤0.01% 898
2017
Q2
$1.38M Sell
40,690
-295
-0.7% -$9.11K ﹤0.01% 919
2017
Q1
$1.19M Buy
40,985
+4,398
+12% +$134K ﹤0.01% 993
2016
Q4
$1.2M Sell
36,587
-8,430
-19% -$253K ﹤0.01% 972
2016
Q3
$1.42M Buy
45,017
+12,439
+38% +$361K 0.01% 865
2016
Q2
$916K Buy
32,578
+2,839
+10% +$111K ﹤0.01% 1046
2016
Q1
$1.08M Sell
29,739
-3,430
-10% -$121K ﹤0.01% 937
2015
Q4
$1.33M Buy
33,169
+2,152
+7% +$75K 0.01% 833
2015
Q3
$884K Buy
31,017
+6,166
+25% +$203K ﹤0.01% 1034
2015
Q2
$819K Buy
24,851
+1,303
+6% +$40.4K ﹤0.01% 1128
2015
Q1
$677K Buy
23,548
+2,541
+12% +$72.9K ﹤0.01% 1207
2014
Q4
$572K Buy
21,007
+2,978
+17% +$71K ﹤0.01% 1275
2014
Q3
$385K Buy
18,029
+2,872
+19% +$65.8K ﹤0.01% 1452
2014
Q2
$340K Buy
15,157
+3,233
+27% +$75.3K ﹤0.01% 1549
2014
Q1
$301K Buy
+11,924
New +$301K ﹤0.01% 1562

Other funds holding EBS